Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NSCLC Harboring NRG1 Fusion × zenocutuzumab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Prostatic Neoplasms 1 Neoplasms, Unknown Primary 1 NSCLC Harboring NRG1 Fusion 1 Lethal Congenital Contracture Syndrome 2 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1

Interventions

zenocutuzumab 1 enzalutamide 1 Afatinib 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05588609 2025-09-18

Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Merus B.V.

Phase 2 Terminated

GenitourinaryThoracic

NSCLC Harboring NRG1 Fusion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡